HMG-CoA reductase inhibitor increases GTP cyclohydrolase I mRNA and tetrahydrobiopterin in vascular endothelial cells - PubMed (original) (raw)
HMG-CoA reductase inhibitor increases GTP cyclohydrolase I mRNA and tetrahydrobiopterin in vascular endothelial cells
Yoshiyuki Hattori et al. Arterioscler Thromb Vasc Biol. 2003.
Abstract
Objective: Endothelial nitric oxide synthase (eNOS) activity is supported by tetrahydrobiopterin (BH4), which appears to be important for generating protective NO but decreases uncoupling formation of superoxide. We investigated the effects of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors, or statins, in terms of BH4 metabolism in human umbilical vein endothelial cells (HUVECs).
Methods and results: We measured the mRNA levels of GTP cyclohydrolase I (GTPCH), the rate-limiting enzyme in the first step of de novo BH4 synthesis, by real-time polymerase chain reaction. The mRNA of GTPCH, as well as of eNOS, was upregulated in HUVECs treated with cerivastatin. This increase was time and dose dependent. Fluvastatin was also observed to enhance GTPCH and eNOS mRNA levels. In parallel with this observation, cerivastatin increased intracellular BH4. Incubating HUVECs with tumor necrosis factor (TNF-alpha) was observed to increase GTPCH mRNA while decreasing eNOS mRNA. In the presence of cerivastatin, the TNF-alpha-mediated increase in GTPCH mRNA was enhanced, and the TNF-alpha-mediated decrease in eNOS mRNA was attenuated. Cerivastatin increased the stability of eNOS mRNA. However, it did not alter the stability of GTPCH mRNA but increased GTPCH gene transcription, as shown by nuclear run-on assays. Preteatment of HUVECs with the selective GTPCH inhibitor, 2,4-diamino-6-hydroxypyrimidine, caused a decrease in intracellular BH4 and decreased citrulline formation after stimulation with ionomycin. Furthermore, the potentiating effect of cerivastatin was decreased by limiting the cellular availability of BH4.
Conclusions: Our data demonstrate that statins elevate GTPCH mRNA, thereby increasing BH4 levels in vascular endothelial cells. In addition to augmenting eNOS expression, statins potentiate GTPCH gene expression and BH4 synthesis, thereby increasing NO production and preventing relative shortages of BH4.
Similar articles
- Fluvastatin upregulates endothelial nitric oxide synthase activity via enhancement of its phosphorylation and expression and via an increase in tetrahydrobiopterin in vascular endothelial cells.
Aoki C, Nakano A, Tanaka S, Yanagi K, Ohta S, Jojima T, Kasai K, Takekawa H, Hirata K, Hattori Y. Aoki C, et al. Int J Cardiol. 2012 Apr 5;156(1):55-61. doi: 10.1016/j.ijcard.2010.10.029. Epub 2010 Nov 18. Int J Cardiol. 2012. PMID: 21093076 - GTP cyclohydrolase I gene transfer augments intracellular tetrahydrobiopterin in human endothelial cells: effects on nitric oxide synthase activity, protein levels and dimerisation.
Cai S, Alp NJ, McDonald D, Smith I, Kay J, Canevari L, Heales S, Channon KM. Cai S, et al. Cardiovasc Res. 2002 Sep;55(4):838-49. doi: 10.1016/s0008-6363(02)00460-1. Cardiovasc Res. 2002. PMID: 12176133 - Statin enhances cytokine-mediated induction of nitric oxide synthesis in vascular smooth muscle cells.
Hattori Y, Nakanishi N, Kasai K. Hattori Y, et al. Cardiovasc Res. 2002 Jun;54(3):649-58. doi: 10.1016/s0008-6363(02)00266-3. Cardiovasc Res. 2002. PMID: 12031711 Retracted. - Malfunction of vascular control in lifestyle-related diseases: endothelial nitric oxide (NO) synthase/NO system in atherosclerosis.
Kawashima S. Kawashima S. J Pharmacol Sci. 2004 Dec;96(4):411-9. doi: 10.1254/jphs.fmj04006x6. J Pharmacol Sci. 2004. PMID: 15613778 Review. - Synthesis and recycling of tetrahydrobiopterin in endothelial function and vascular disease.
Crabtree MJ, Channon KM. Crabtree MJ, et al. Nitric Oxide. 2011 Aug 1;25(2):81-8. doi: 10.1016/j.niox.2011.04.004. Epub 2011 Apr 22. Nitric Oxide. 2011. PMID: 21550412 Free PMC article. Review.
Cited by
- Free radical production by dysfunctional eNOS.
Verhaar MC, Westerweel PE, van Zonneveld AJ, Rabelink TJ. Verhaar MC, et al. Heart. 2004 May;90(5):494-5. doi: 10.1136/hrt.2003.029405. Heart. 2004. PMID: 15084540 Free PMC article. Review. No abstract available. - Endothelial dysfunction due to eNOS uncoupling: molecular mechanisms as potential therapeutic targets.
Janaszak-Jasiecka A, Płoska A, Wierońska JM, Dobrucki LW, Kalinowski L. Janaszak-Jasiecka A, et al. Cell Mol Biol Lett. 2023 Mar 9;28(1):21. doi: 10.1186/s11658-023-00423-2. Cell Mol Biol Lett. 2023. PMID: 36890458 Free PMC article. - Statins in acute brain injury: getting the cart before the horse.
Laskowitz DT, Warner DS. Laskowitz DT, et al. Neurocrit Care. 2008;8(1):3-5. doi: 10.1007/s12028-007-9040-0. Neurocrit Care. 2008. PMID: 18094941 No abstract available. - Differential modulation of nitric oxide synthases in aging: therapeutic opportunities.
Cau SB, Carneiro FS, Tostes RC. Cau SB, et al. Front Physiol. 2012 Jun 25;3:218. doi: 10.3389/fphys.2012.00218. eCollection 2012. Front Physiol. 2012. PMID: 22737132 Free PMC article. - Nitric oxide synthases in heart failure.
Carnicer R, Crabtree MJ, Sivakumaran V, Casadei B, Kass DA. Carnicer R, et al. Antioxid Redox Signal. 2013 Mar 20;18(9):1078-99. doi: 10.1089/ars.2012.4824. Epub 2012 Sep 20. Antioxid Redox Signal. 2013. PMID: 22871241 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical